Although the relationship between KRASG12D and the onset/initiation of pancreatic cancer has been clarified through studies on genetically engineered mouse models, the specific carcinogenic mechanisms, especially other molecular alterations that help promoting KRAS-driven cancer progression, remains unclear (8). This evidence concerns the gene KRAS and familial pancreatic carcinoma.